TCTR20220817002UnknownNot Applicable
Effects of testosterone on bone turnover markers in transgender male.
King Chulalongkorn Memorial Hospital0 sites22 target enrollmentStarted: August 17, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 22
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 20 Years (—)
- Sex
- Female
Inclusion Criteria
- •Adults diagnosed with gender dysphoria (based on DSM V) by psychiatrist
- •Age 20 to 40 years old
- •Never used cross-sex hormone therapy
Exclusion Criteria
- •Underlying disease (Cardiovascular, stroke, VTE, DLP, OSA)
- •Endometrial cancer, breast cancer
- •HIV infections
- •Bone metastasis, pathological fracture
- •Impaired renal function (GFR<15)
- •Parathyroid, thyroid abnormalities
- •Anti-osteoporotic drugs (bisphosphonate, denosumab, teriparatide, SERMs)
- •Hormonal drug use (aromatase inhibitor, OCPs)
- •Corticosteroid use
- •Anti-epileptic drugs (phenytoin, phenobarbital,carbamazepine)
Investigators
Similar Trials
Completed
Phase 4
Testosterone Effects on Bone and FrailtyAgingFrailtyOsteoporosisNCT00182871National Institute on Aging (NIA)140
Recruiting
Not Applicable
effect of biochemical markers of bone turnover for treating and predicting fracture risk risk of metabolic bone diseaseosteoporosisJPRN-UMIN000008979Osaka City University Graduate School of Medicine400
Recruiting
Not Applicable
effect of biochemical markers of bone turnover for predicting fracture risk and changes of the bone mineral density in a long-term cohort studyosteopeniaJPRN-UMIN000008977Osaka City University Graduate School of Medicine300
Completed
Not Applicable
Dose-Response of Gonadal Steroids and Bone Turnover in Older MenHealthy VolunteersNCT00114114Massachusetts General Hospital177
Recruiting
Phase 2
The use of testosterone in brain dead patients who are candidates for organ donation in order to maintain and stabilize blood pressurebrain dead.Other specified disorders of central nervous systemG96.8IRCT20130304012695N17Tehran University of Medical Sciences80